Suppr超能文献

FcγRI(CD64):肠道巨噬细胞的身份证。

FcγRI (CD64): an identity card for intestinal macrophages.

机构信息

Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Eur J Immunol. 2012 Dec;42(12):3136-40. doi: 10.1002/eji.201243061.

Abstract

Macrophages are becoming increasingly recognized as key cellular players in intestinal immune homeostasis. However, differentiating between macrophages and dendritic cells (DCs) is often difficult, and finding a specific phenotypic signature for intestinal macrophage identification has remained elusive. In this issue of the European Journal of Immunology, Tamoutounour et al. [Eur. J. Immunol. 2012. 42: 3150-3166] identify CD64 as a specific macrophage marker that can be used to discriminate DCs from macrophages in the murine small and large intestine, under both steady-state and inflammatory conditions. The authors also propose a sequential 'monocyte-waterfall' model for intestinal macrophage differentiation, with implications for immune tolerance and inflammation at the gut mucosal interface. This Commentary will discuss the advantages and potential limitations of CD64 as a marker for intestinal macrophages.

摘要

巨噬细胞越来越被认为是肠道免疫稳态中的关键细胞。然而,巨噬细胞和树突状细胞(DC)之间的区分往往很困难,并且寻找用于鉴定肠道巨噬细胞的特定表型特征仍然难以捉摸。在本期的《欧洲免疫学杂志》中,Tamoutounour 等人 [Eur. J. Immunol. 2012. 42: 3150-3166] 确定 CD64 是一种特异性巨噬细胞标志物,可用于在稳态和炎症条件下区分小鼠小肠和大肠中的 DC 和巨噬细胞。作者还提出了一个肠道巨噬细胞分化的顺序“单核细胞瀑布”模型,这对肠道黏膜界面的免疫耐受和炎症具有重要意义。本评论将讨论 CD64 作为肠道巨噬细胞标志物的优势和潜在局限性。

相似文献

7
Tolerance in intestinal inflammation and cancer.肠道炎症和癌症中的耐受性。
Curr Drug Targets. 2008 May;9(5):404-12. doi: 10.2174/138945008784221143.

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验